Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Biotie Therapies OYJ

+ Add to Watchlist

BTH1V:FH

0.1870 EUR 0.0030 1.58%

As of 03:36:14 ET on 03/04/2015.

Snapshot for Biotie Therapies OYJ (BTH1V)

Open: 0.1900 Day's Range: 0.1870 - 0.1900 Volume: 59,175
Previous Close: 0.1900 52wk Range: 0.1820 - 0.3100 1-Yr Rtn: -37.33%

Stock Chart for BTH1V

No chart data available.
  • BTH1V:FH 0.1870
  • 1D
  • 1M
  • 1Y
0.1900
Interactive BTH1V Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BTH1V

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. HEXP -
Earnings Per Share (EUR) (ttm) -0.0745
Est. EPS (EUR) (12/2015) -0.0500
Est. PEG Ratio -
Market Cap (M EUR) 86.18
Shares Outstanding (M) 455.97
30 Day Average Volume 827,525
Price/Book (mrq) 1.0003
Price/Sale (ttm) 5.7535
Dividend Indicated Gross Yield -%
Cash Dividend (EUR) -
Dividend Ex-Date 03/30/2006
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BTH1V

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for BTH1V

Biotie Therapies Oyj is a biopharmaceutical company. The Company develops drugs that treat dependence disorders, inflammatory diseases, and thrombosis.

Timo VeromaaPresident/CEODavid CookCFO/Chief Business Ofcr
Stephen I BandakChief Medical OfficerIan J MasseyPresident:US Operations/COO
More Company Profile & Key Executives for BTH1V

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil